Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-May-23 4:45 PM View:  | Avantor, Inc. (AVTR) | 11-May-23 | Grant | 9,808 | -- | -- | 6% 176.34K to 186.15K | |
| 16-May-22 6:13 PM View: | Avantor, Inc. (AVTR) | 12-May-22 | Grant | 6,693 | -- | -- | 4% 169.65K to 176.34K | |
| 05-Apr-22 4:59 PM View: | Avantor, Inc. (AVTR) | 01-Apr-22 | Grant | 1,215 | -- | -- | < 1% 168.43K to 169.65K | |
| 02-Apr-21 4:10 PM View: | Bellerophon Therapeutics, I... (BLPH) | 31-Mar-21 | Grant | 15,308 | -- | -- | 11% 141.72K to 157.03K | |
| 01-Mar-21 5:38 PM View: | Avantor, Inc. (AVTR) | 25-Feb-21 | Grant | 7,236 | -- | -- | 4% 161.19K to 168.43K | |
| 25-Feb-20 5:29 PM View: | Avantor, Inc. (AVTR) | 21-Feb-20 | Grant | 11,319 | -- | -- | 8% 149.88K to 161.19K | |
| 27-Jan-20 4:51 PM View: | Bellerophon Therapeutics, I... (BLPH) | 23-Jan-20 | Grant | 350,000 | -- | -- | 19% 1.88M to 2.23M | |
| 22-May-19 11:14 AM View: | Bellerophon Therapeutics, I... (BLPH) | 21-May-19 | Market Purchase | 20,000 | $0.61 | $12,198.00 | 1% 1.86M to 1.88M | (8%) |
| 23-May-19 7:28 PM View: | Avantor, Inc. (AVTR) | 21-May-19 | Grant | 14,286 | -- | -- | 145% 9.86K to 24.14K | |
| 23-May-19 7:28 PM View: | Avantor, Inc. (AVTR) | 21-May-19 | Option Exercise | 117,857 | -- | -- | 488% 24.14K to 142.0K | |
| 25-Jan-19 4:21 PM View: | Bellerophon Therapeutics, I... (BLPH) | 25-Jan-19 | Market Purchase | 714,286 | $0.70 | $500,000.00 | 63% 1.14M to 1.86M | (20%) |
| 25-Jan-19 4:21 PM View: | Bellerophon Therapeutics, I... (BLPH) | 23-Jan-19 | Grant | 227,273 | -- | -- | 25% 914.36K to 1.14M | |
| 03-Apr-18 5:40 PM View: | Bellerophon Therapeutics, I... (BLPH) | 02-Apr-18 | Grant | 99,010 | -- | -- | 12% 815.35K to 914.36K | |
| 05-Oct-17 8:28 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (3%) 69.74K to 67.93K | |
| 05-Oct-17 8:28 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 67,932 | $180.00 | $12,227,800.00 | (100%) 67.93K to 0 | |
| 03-Oct-17 4:06 PM View: | Bellerophon Therapeutics, I... (BLPH) | 29-Sep-17 | Purchase | 248,962 | -- | -- | 44% 566.39K to 815.35K | |
| 05-Oct-17 8:28 PM View: | Kite Pharma, Inc. (KITE) | 13-Sep-17 | Gift | 635 | -- | -- | (< 1%) 70.37K to 69.74K | |
| 30-Jun-17 6:44 PM View: | Bellerophon Therapeutics, I... (BLPH) | 28-Jun-17 | Grant | 57,972 | -- | -- | 11% 508.42K to 566.39K | |
| 22-Jun-17 2:34 PM View: | Kite Pharma, Inc. (KITE) | 20-Jun-17 | Grant | 2,410 | -- | -- | 4% 67.96K to 70.37K | |
| 30-Nov-16 3:31 PM View: | Bellerophon Therapeutics, I... (BLPH) | 29-Nov-16 | Purchase | 285,715 | -- | -- | 128% 222.7K to 508.42K | |
| 03-Jun-16 7:15 PM View: | Kite Pharma, Inc. (KITE) | 01-Jun-16 | Grant | 1,950 | -- | -- | 3% 66.01K to 67.96K | |
| 18-May-16 1:46 PM View: | Bellerophon Therapeutics, I... (BLPH) | 17-May-16 | Market Purchase | 5,000 | $1.37 | $6,841.50 | 2% 217.7K to 222.7K | (45%) |
| 27-Jan-16 4:18 PM View: | Bellerophon Therapeutics, I... (BLPH) | 25-Jan-16 | Grant | 165,975 | -- | -- | 321% 51.73K to 217.7K | |
| 17-Dec-15 5:01 PM View: | Bellerophon Therapeutics, I... (BLPH) | 16-Dec-15 | Market Purchase | 12,800 | $2.76 | $35,335.70 | 33% 38.93K to 51.73K | (73%) |
| 17-Dec-15 5:01 PM View: | Bellerophon Therapeutics, I... (BLPH) | 15-Dec-15 | Market Purchase | 7,500 | $2.72 | $20,400.00 | 24% 31.43K to 38.93K | (72%) |
| 20-Aug-15 5:34 PM View: | Bellerophon Therapeutics, I... (BLPH) | 19-Aug-15 | Market Purchase | 5,000 | $5.48 | $27,377.00 | 19% 26.43K to 31.43K | (86%) |
| 22-May-15 7:32 AM View: | Bellerophon Therapeutics, I... (BLPH) | 20-May-15 | Market Purchase | 5,560 | $8.69 | $48,323.10 | 27% 20.87K to 26.43K | (91%) |
| 23-Feb-15 9:39 PM View: | Bellerophon Therapeutics, I... (BLPH) | 19-Feb-15 | Purchase | 20,800 | $12.00 | $249,600.00 | 31045% 67 to 20.87K | |
| 27-Jun-14 5:52 PM View: | Kite Pharma, Inc. (KITE) | 25-Jun-14 | Acquisition (other) | 66,014 | $15.30 | $1,010,010.00 | 100% 0 to 66.01K | |
| 29-Oct-13 6:22 PM View: | Amgen Inc. (AMGN) | 28-Oct-13 | Payment of Exercise | 13,045 | $116.32 | $1,517,390.00 | (12%) 107.46K to 94.41K | (76%) |
| 29-Apr-13 6:10 PM View: | Amgen Inc. (AMGN) | 25-Apr-13 | Payment of Exercise | 2,721 | $104.93 | $285,515.00 | (2%) 110.03K to 107.31K | (93%) |
| 30-Jan-13 8:18 PM View: | Amgen Inc. (AMGN) | 28-Jan-13 | Grant | 7,477 | -- | -- | 7% 102.47K to 109.95K | |
| 29-Oct-12 8:05 PM View: | Amgen Inc. (AMGN) | 28-Oct-12 | Payment of Exercise | 11,671 | $87.63 | $1,022,730.00 | (10%) 114.11K to 102.44K | (129%) |
| 01-May-12 9:02 PM View: | Amgen Inc. (AMGN) | 27-Apr-12 | Grant | 8,654 | -- | -- | 8% 105.37K to 114.03K | |
| 31-Oct-11 7:59 PM View: | Amgen Inc. (AMGN) | 28-Oct-11 | Payment of Exercise | 10,427 | $58.06 | $605,392.00 | (9%) 115.8K to 105.37K | (253%) |
| 27-Apr-11 9:16 PM View: | Amgen Inc. (AMGN) | 25-Apr-11 | Grant | 15,800 | -- | -- | 16% 100.0K to 115.8K | |
| 29-Oct-10 8:50 PM View: | Amgen Inc. (AMGN) | 28-Oct-10 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K |